Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

Nat Med. 2024 Jun;30(6):1784. doi: 10.1038/s41591-024-02883-1.
No abstract available

Publication types

  • Published Erratum